DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Neuropeptide Y is an investigational drug.
There have been 5 clinical trials for Neuropeptide Y. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2015.
The most common disease conditions in clinical trials are Disease, Stress Disorders, Traumatic, and Stress Disorders, Post-Traumatic. The leading clinical trial sponsors are James Murrough, Dennis Charney, and University of Texas Southwestern Medical Center.
There are two hundred and sixty-nine US patents protecting this investigational drug and three international patents.
Recent Clinical Trials for Neuropeptide Y
|Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)||University of Texas Southwestern Medical Center||Early Phase 1|
|Intranasal Neuropeptide Y in Clinical Trial in Level Two Trauma Patients for PTSD and Acute Stress Disorder||U.S. Army Medical Research and Development Command||Phase 1/Phase 2|
|Intranasal Neuropeptide Y in Clinical Trial in Level Two Trauma Patients for PTSD and Acute Stress Disorder||Westchester Medical Center||Phase 1/Phase 2|
Top disease conditions for Neuropeptide Y
Top clinical trial sponsors for Neuropeptide Y
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Neuropeptide Y||Try Before You Buy||Neuropeptide Y-derived peptides||University of Copenhagen (Copenhagen K, DK) N.ae butted.stved Hospital (N.ae butted.stved, DK)||Try Before You Buy|
|Neuropeptide Y||Try Before You Buy||Methods for the treatment of kidney fibrosis||THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (Boston, MA)||Try Before You Buy|
|Neuropeptide Y||Try Before You Buy||Method using an Y1 receptor activator for treating an anticancer agent-induced nephrotoxic injury||KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR)||Try Before You Buy|
|Neuropeptide Y||Try Before You Buy||Diagnostic method for diagnosing depression and monitoring therapy effectiveness||BRAINLABS B.V. (NL) RIJKSUNIVERSITEIT GRONINGEN (NL) ACADEMISCH ZIEKENHUIS GRONINGEN (NL)||Try Before You Buy|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Neuropeptide Y||Denmark||DK2983690||2033-04-10||Try Before You Buy|
|Neuropeptide Y||European Patent Office||EP2983690||2033-04-10||Try Before You Buy|
|Neuropeptide Y||Spain||ES2729970||2033-04-10||Try Before You Buy|
|Neuropeptide Y||Poland||PL2983690||2033-04-10||Try Before You Buy|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|